Drug profile · INN
lixisenatide
LYXUMIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
lixisenatide (LYXUMIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN lixisenatide
Brand LYXUMIA
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code A10BJ03
Frequently asked questions
What is lixisenatide?
lixisenatide (LYXUMIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for lixisenatide?
LYXUMIA is a marketed brand name for lixisenatide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lixisenatide?
lixisenatide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.